Sophoridine alleviates spleen injury in sepsis by inhibiting ASK1-mediated inflammation, oxidative stress, and apoptosis

Key Points

• Sophoridine effectively reduces markers of spleen injury and oxidative stress in sepsis.
• Key metrics show a significant decrease in ASK1 activation and inflammation markers after sophoridine treatment.
• The study utilizes an observational analysis focusing on sepsis-induced spleen damage and related mechanisms.
• Findings support the potential of sophoridine as a beneficial intervention in sepsis, warranting further exploration.